James Shapiro, MD, PhD
University of Alberta · Clinical Islet Transplant Program, University of Alberta
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name James Shapiro, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 09:34 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05349591 · cePolyTregs in Islet TransplantationUniversity of Alberta · withdrawn · Diabetes type1
- Ph1NCT05073302 · Device-Less Technique in Islet TransplantationUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph1NCT03444064 · PolyTreg Immunotherapy in Islet TransplantationUniversity of Alberta · completed · Diabetes, Diabetes Mellitus, Type 1 · principal investigator
- Ph1/Ph2NCT03182426 · Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM)University of Alberta · completed · Diabetes Mellitus, Type 1 · principal investigator
- Ph1/Ph2NCT03089840 · Normothermic Liver Preservation TrialUniversity of Alberta · completed · End Stage Liver Disease, Liver Diseases · principal investigator
- Ph1NCT03073577 · Islet Transplantation Using PKX-001University of Alberta · completed · Type 1 Diabetes Mellitus · principal investigator
- Ph1/Ph2NCT02520076 · Aralast NP in Islet TransplantUniversity of Alberta · completed · Type 1 Diabetes Mellitus · principal investigator
- Ph1NCT02457858 · Islet Isolation Using MnTE-2-PyP (BMX-010) - Pilot StudyUniversity of Alberta · completed · Type 1 Diabetes
- Ph1/Ph2NCT01653899 · Caspase Inhibition in Islet TransplantationUniversity of Alberta · completed · Diabetes
- Ph1/Ph2NCT01652911 · A Phase I/II Study of the Safety and Efficacy of Sernova's Cell PouchTM for Therapeutic Islet TransplantationUniversity of Alberta · terminated · Type I Diabetes · principal investigator
- Ph2NCT00769873 · Anticoagulation Post Laparoscopic SplenectomyUniversity of Alberta · terminated · Portal Vein Thrombosis, Splenic Vein Thrombosis
- Ph2NCT00468403 · LEA29Y (Belatacept) Emory Edmonton ProtocolNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Type 1 Diabetes Mellitus · study chair
- Ph3NCT00434811 · Islet Transplantation in Type 1 DiabetesNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Type 1 Diabetes Mellitus · study chair
- Ph2NCT00175266 · Islet Transplantation Using Campath-1H and Infliximab InductionUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph2NCT00175253 · Alemtuzumab Induction in Islet TransplantationUniversity of Alberta · completed · Type 1 Diabetes · principal investigator
- Ph2NCT00014911 · Islet Transplantation for Type 1 DiabetesNational Institute of Allergy and Infectious Diseases (NIAID) · completed · Diabetes Mellitus, Insulin-Dependent · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 09:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.